How has a smart biopsy become a less intrusive process with the smart needle?
Since scientists developed a new
"smart needle" for smart biopsy which
uses a mini laser to classify diseased tissue within seconds, cancer detection
could become much faster and easier in the future. Researchers have shown the
laboratory works of the technique and have just launched a big three-year
clinical trial to test it in living people.
Researchers have so far
concentrated on lymphoma but are optimistic that the procedure may also be used
to treat other aspects of the disease further down the line, such as breast and
prostate cancer. Apparently, lymphoma detection can be an invasive process
involving a surgical biopsy followed by a nerve-wracking wait for the test that
can often take two weeks or more.
What is biopsy technology?
A biopsy is a tissue sample taken
from the body for closer examination. If an initial test indicates that a
tissue area in the body is not normal, a doctor may prescribe a biopsy. Doctors
can label an area of abnormal tissue a lesion, a tumor, or a mass. These are
common terms used to illustrate the tissue's unknown existence. During a
physical examination or internally on an MRI scan, the abnormal area may be
identified.
Cancer is spreading worldwide more than ever before
There is a dramatic increase in
the number of tumors detected in the world population, with cancer becoming the
world’s second major cause of death. The estimated number of people with cancer
has more than doubled in recent years. Higher-income countries have shown a
higher prevalence of cancer diseases, especially due to lifestyle habits such
as smoking, lack of exercise, alcohol intake, unstable diet, and obesity. This
has resulted in increased attention to detection, as early diagnosis of cancer
is essential to ensure a high chance of survival for patients.
Maternal deaths, according to the
World Health Organization, lead to disparities in life expectancy at birth
between men and women more than any other cause. For low-income nations,
maternal deaths are high, mostly due to a lack of access to basic health
services. The life expectancy of men, especially in higher-income countries, is
lower than that of women because of the higher death rate from common causes.
The net impact of breast and cervical cancer decreases the life expectancy
differences between men and women in such countries as compared to high-income
countries.
Real-world application development for smart biopsy technology
Throughout the world, the
outcomes of cancer treatment are often associated with early detection and
care. Cancers including prostate, cervical cancer, colorectal cancer, and oral
cancer have all been the subjects of research into the use of DRS for rapid and
precise cancer detection. Early detection and treatment in the developed world
have resulted in lower fatality rates for epithelial cancers, but current DRS
diagnostic equipment is costly, bulky, and requires high power output.
It also needs highly trained
personnel. Because of the lack of diagnostic equipment, these barriers lead to
low and middle-income countries having relatively high mortality rates for
these cancers. Developing a compact, low-cost, easy-to-use, and most
importantly, an effective diagnostic tool for epithelial cancer detection would
save lives around the globe.
Smart biopsy for skin cancer
The science of fusion biopsy is a
smart biopsy based on MRI scanning. During the test, the radiologist may find
unusual areas and combine the MRI information with ultrasound images. The
combination (fusion) allows for more precise targeting of the biopsy to suspect
areas rather than blind penetration and an improvement in disease detection
rate. The biopsy is performed by a urologist, who uses a small needle to take a
small tissue sample from the prostate. A tissue specimen is then sent for
microscopic examination to the pathological laboratory.
Smart biopsy for breast cancer
Breast cancer is the world's
second most common cancer among women, and the use of population-based
screening services has increased demand for more responsive and accurate
detection methods to limit the number of patients misdiagnosed or over-treated.
A review of animal tissue response to electrical impedance (beef, lamb, and
pork) found that a number of tissues (fat, muscle, and liver) can be
discriminated against using experimental gold electrodes to detect distinct
electrical responses.
There are a number of potential
applications for this tool including the improved position of biopsy,
cancer-free border determination during a lumpectomy, and the prospect of
assessing DCIS without invasive surgery. Smart novel tools are intended to be
used mainly as an alternative to the x-ray mammography gold standard for
detecting breast cancer tumors during the routine screening process.
To sum up
The smart biopsy
market is growing bigger and better due to its concept of being a
minimally invasive surgical procedure that can remove the complications and
side-effects of biopsy devices. Today, the idea of a smart biopsy or endoscopy
may refer to the use of a biopsy or endoscopy technique to obtain deeper data
from these invasive procedures that may help in diagnostic processes. Future
smart biopsy aims to develop a fast and minimally invasive diagnostic tool that
can reduce the number of needless conventional invasive biopsies when
implemented in a clinical setting and improve early detection and treatment of
a variety of diseases in the developing world.
Comments
Post a Comment